Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers.
about
Cerebral microdialysis for protein biomarker monitoring in the neurointensive care setting - a technical approachCapillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developmentsProteome profiling of human cerebrospinal fluid: exploring the potential of capillary electrophoresis with surface modified capillaries for analysis of complex biological samples.Removal of albumin and immunoglobulins from canine cerebrospinal fluid using depletion kits: a feasibility study.cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases.Use of electrophoretic techniques and MALDI-TOF MS for rapid and reliable characterization of bacteria: analysis of intact cells, cell lysates, and "washed pellets".A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles.Multivariate proteomic analysis of the cerebrospinal fluid of patients with peripheral neuropathic pain and healthy controls - a hypothesis-generating pilot studyComparative peptidome analyses of the profiles of the peptides ranging from 1-10 KD in CSF samples pooled from probable sporadic CJD and non-CJD patients.Total protein is an effective loading control for cerebrospinal fluid western blotsMS for investigation of time-dependent protein adsorption on surfaces in complex biological samples.Protein changes in immunodepleted cerebrospinal fluid from a transgenic mouse model of Alexander disease detected using mass spectrometryMass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery.Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasmaProteomic profiling of cerebrospinal fluid in Creutzfeldt-Jakob disease.From "clinical proteomics" to "clinical chemistry proteomics": considerations using quantitative mass-spectrometry as a model approach.Role of proteomics in biomarker discovery and psychiatric disorders: current status, potentials, limitations and future challenges.Glia-based biomarkers and their functional role in the CNS.The pig as an animal model for human pathologies: A proteomics perspective.The contribution of proteomic studies in humans, animal models, and after antidepressant treatments to investigate the molecular neurobiology of major depression.Spectral counting assessment of protein dynamic range in cerebrospinal fluid following depletion with plasma-designed immunoaffinity columnsAmyloid-β as a biomarker for Alzheimer's disease: quantification methods in body fluids.Pain in the Blood? Envisioning Mechanism-Based Diagnoses and Biomarkers in Clinical Pain Medicine.Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies.Stable Isotope Labeling by Amino acid in Vivo (SILAV): a new method to explore protein metabolism.Modern cerebrospinal fluid flow research and Heinrich Quincke's seminal 1872 article on the distribution of cinnabar in freely moving animals.Cerebrospinal fluid beta-amyloid and dynabridging in Alzheimer's disease drug development.High levels of cerebrospinal fluid chemokines point to the presence of neuroinflammation in peripheral neuropathic pain: a cross-sectional study of 2 cohorts of patients compared with healthy controls.Cerebrospinal fluid proteomics in children during induction for acute lymphoblastic leukemia: A pilot study.Do fragments and glycosylated isoforms of alpha-1-antitrypsin in CSF mirror spinal pathophysiological mechanisms in chronic peripheral neuropathic pain? An exploratory, discovery phase study
P2860
Q26830132-730FD66A-7FB2-40C6-9E38-EDA77235132DQ30438814-551EB43B-91E1-4E30-91EB-983938C100B0Q33364699-5E32ED6E-0F50-4A14-B84A-4E9CA00F49B4Q33838104-64C1AF35-AFB1-4109-B0C3-DDBC5F2921D8Q34155662-3977C1DC-9241-4A78-8151-AC13A9922D9AQ34579028-4A15FA05-1F6A-44B3-B0B4-66459A603049Q34630534-C5592327-FDE7-4843-9972-25E1103368A9Q35821983-DBD7D25D-5813-4A3D-9CE7-4D56478CBADEQ35918933-6F26AB6C-C051-4CEC-A9E4-0D9838971CB5Q35966833-A02BCC61-1492-4F91-99A4-1FCE51B46739Q36235206-2BF0AD6D-3322-4016-A330-22C394B680D8Q36599253-4304D9F6-35BD-44A0-A149-BDD7DD0DBE41Q37552845-CCACC8F3-545F-4B41-89B0-E2889999D1A0Q37691644-6AB2D11A-C9E0-43BD-A0A9-44A32D76FAA6Q37818319-839016A1-E575-4C24-8B9D-4E681F7FE130Q37943426-E157C39A-4F7A-459B-B004-94941C16629CQ38027217-996FACE4-04FA-4071-AE4E-679B07DAAFB7Q38081955-1E333448-2670-451C-B9B0-B2645D6E8B22Q38237026-2C3DCCAC-6CB7-46BC-9DA6-8C6219924ED8Q38285544-4C67A9C7-7D56-4AB7-9095-FE0887F58BC1Q38311018-608C95B6-1763-4862-A58E-B18C0B34652DQ38543843-F218C206-017D-405E-B5F3-5BCB86474252Q38911074-B77005BB-3570-42A1-80E9-1331174BDB4FQ39340736-99826C54-80B6-46DC-95B4-A6DE12F6913BQ40495056-0025DD5B-645E-4A73-9534-75619273BAD4Q42032643-6B5327F5-2A3A-4585-9D08-B5016D38899DQ43861285-22FC48B6-E46F-48A0-9FEF-608DD03EE10EQ47131129-14362AA1-AA97-4FD6-A267-C63834028028Q48262886-187363C2-2D27-40E8-AEFC-D8AA97EAF0DFQ57168949-C3A4D1B2-C090-40E4-B6EA-71F76BA9D968
P2860
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers.
@en
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers.
@nl
type
label
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers.
@en
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers.
@nl
prefLabel
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers.
@en
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers.
@nl
P356
P1476
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers.
@en
P2093
Audrey Gabelle
P2860
P304
P356
10.1002/PRCA.200780040
P577
2008-03-01T00:00:00Z